Purpose of Review
Despite the significant burden of inpatient hospitalization for AD, there are few reviews of inpatient management of AD. In this review, we address common indications for hospitalization in AD patients, the role of dermatology consultation, treatment considerations, and discharge planning.
There are significant socioeconomic and racial/ethnic disparities that lead to increased risk of hospitalization and readmission for AD. A significant burden of mental health disorders in patients with AD can result in psychiatric emergencies and hospitalization in AD patients.
The mainstay of hospital treatment for severe or refractory AD remains topical corticosteroid wet wraps. Dermatology should be consulted early in the hospital course. In order to prevent readmission, patients with AD need to be discharged with timely outpatient follow-up to ensure both short-term and long-term disease control. Finally, patients hospitalized for AD may benefit from a multidisciplinary team that can also address their other health conditions and barriers to care.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Topical calcineurin inhibitors
Randomized controlled trial
Scoring atopic dermatitis
Joint Task Force Practice Parameter
- SCID :
Severe combined immunodeficiency
Calcium channel blocker
Eczema action plan
Patient Health Questionnaire
Quick Sequential [Sepsis-related] Organ Failure Assessment
c-reactive protein; ESR = Erythrocyte sedimentation rate
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Hua T, Silverberg JI. Atopic dermatitis in US adults: epidemiology, association with marital status, and atopy. Ann Allergy Asthma Immunol. 2018;121(5):622–4.
Sacotte R, Silverberg JI. Epidemiology of adult atopic dermatitis. Clin Dermatol. 2018;36(5):595–605.
Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–9.
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–7.
Silverberg JI, Simpson EL. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr Allergy Immunol. 2013;24(5):476–86.
Silverberg JI, Simpson EL. Associations of childhood eczema severity: a US population-based study. Dermatitis. 2014;25(3):107–14.
Langan SM, Silcocks P, Williams HC. What causes flares of eczema in children? Br J Dermatol. 2009;161(3):640–6.
Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol. 2015;135(1):56–66.
Silverberg JI, et al. Pain is a common and burdensome symptom of atopic dermatitis in united states adults. J Allergy Clin Immunol Pract. 2019;7(8):2699–2706.e7 This cross-sectional study found a high prevalence of skin pain in AD patients and the skin pain negatively impacted patients’ quality of life; recommends that the frequency and intensity of pain also be assessed in clinical practice annd/or future AD trials.
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol. 2019;181(3):554–65.
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Health utility scores of atopic dermatitis in US adults. J Allergy Clin Immunol Pract. 2019;7(4):1246–52 e1.
Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, et al. Association of atopic dermatitis severity with cognitive function in adults. J Am Acad Dermatol. 2020;83(5):1349–59.
Vakharia PP, Chopra R, Sacotte R, Patel KR, Singam V, Patel N, et al. Burden of skin pain in atopic dermatitis. Ann Allergy Asthma Immunol. 2017;119(6):548–52 e3.
Yu SH, Attarian H, Zee P, Silverberg JI. Burden of sleep and fatigue in US adults with atopic dermatitis. Dermatitis. 2016;27(2):50–8.
Silverberg JI. Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol. 2017;35(4):360–6.
Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):144–51 A comprehensive review of the comorbidities associated with AD.
Silverberg JI, et al. Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. Ann Allergy Asthma Immunol. 2018;121(5):604–612.e3.
Hsu DY, Gordon K, Silverberg JI. Serious infections in hospitalized patients with psoriasis in the United States. J Am Acad Dermatol. 2016;75(2):287–96.
Narla S, Silverberg JI. Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults. Ann Allergy Asthma Immunol. 2018;120(1):66–72.e11.
Ren Z, Silverberg JI. Association of atopic dermatitis with bacterial, fungal, viral, and sexually transmitted skin infections. Dermatitis. 2020;31(2):157–64.
Serrano L, Patel KR, Silverberg JI. Association between atopic dermatitis and extracutaneous bacterial and mycobacterial infections: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(4):904–12.
Silverberg JI, Silverberg NB. Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. J Allergy Clin Immunol. 2014;133(4):1041–7.
Strom MA, Silverberg JI. Association between atopic dermatitis and extracutaneous infections in US adults. Br J Dermatol. 2017;176(2):495–7.
Cheng BT, Silverberg JI. Predictors of hospital readmission in United States adults with psoriasis. J Am Acad Dermatol. 2020;82(4):902–9.
Hua T, Silverberg JI. Atopic dermatitis is associated with increased hospitalization in US children. J Am Acad Dermatol. 2019;81(3):862–5.
Narla S, Hsu DY, Thyssen JP, Silverberg JI. Predictors of hospitalization, length of stay, and costs of care among adult and pediatric inpatients with atopic dermatitis in the United States. Dermatitis. 2018;29(1):22–31.
Hsu DY, Smith B, Silverberg JI. Atopic dermatitis and hospitalization for mental health disorders in the United States. Dermatitis : contact, atopic, occupational, drug. Dermatitis. 2019;30(1):54–61 Patients with AD were found to have higher rates of hospitalization for all mental health disorders.
Narla S, Hsu DY, Thyssen JP, Silverberg JI. Inpatient financial burden of atopic dermatitis in the United States. J Investig Dermatol. 2017;137(7):1461–7.
Boguniewicz M, et al. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1):10–22.e2.
Baum S, Porat S, Lyakhovitsky A, Astman N, Barzilai A. Adult atopic dermatitis in hospitalized patients: comparison between those with childhood-onset and late-onset disease. Dermatology. 2019;235(5):365–71.
LeBovidge JS, Elverson W, Timmons KG, Hawryluk EB, Rea C, Lee M, et al. Multidisciplinary interventions in the management of atopic dermatitis. J Allergy Clin Immunol. 2016;138(2):325–34.
Vermeulen FM, Gerbens LAA, Schmitt J, Deleuran M, Irvine AD, Logan K, et al. The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate-to-severe atopic eczema*. Br J Dermatol. 2020;183(6):1073–82.
Narla S, Silverberg JI. Association between childhood atopic dermatitis and cutaneous, extracutaneous and systemic infections. Br J Dermatol. 2018;178(6):1467–8.
Silverberg J. Associations between atopic dermatitis and other disorders [version 1; peer review: 3 approved]. F1000Research. 2018;7(303).
Dugar S, Choudhary C, Duggal A. Sepsis and septic shock: guideline-based management. Cleve Clin J Med. 2020;87(1):53–64.
Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician. 1999;60(5):1443–50.
Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr. 2015;38(3):93–4.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.
Yoder JC, Yuen TC, Churpek MM, Arora VM, Edelson DP. A prospective study of nighttime vital sign monitoring frequency and risk of clinical deterioration. JAMA Intern Med. 2013;173(16):1554–5.
Ramakrishnan K, Salinas RC, Agudelo Higuita NI. Skin and soft tissue infections. Am Fam Physician. 2015;92(6):474–83.
Alexander H, Paller AS, Traidl-Hoffmann C, Beck LA, de Benedetto A, Dhar S, et al. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. Br J Dermatol. 2020;182(6):1331–42.
Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol. 2010;163(1):12–26.
Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):428–33.
Kage P, Simon J-C, Treudler R. Atopic dermatitis and psychosocial comorbidities. JDDG. 2020;18(2):93–102.
Pongdee T. Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults. Pediatrics. 2017;140(Supplement 3):S206.
Kataoka Y, Nakajima S. Is coping of atopic dermatitis patients originated from their own character or secondarily remodeled by disease suffering? Obvious improvement of coping and psychiatric symptoms after “tight eczema control”. in Acta Dermato-venereologica. Tradgardsgatan 14, Uppsala, SE-753 09, Sweden; 2017.
Vinnik T, Kirby M, Bairachnaya M, Koman I, Tarkina T, Sadykova G, et al. Seasonality and BDNF polymorphism influences depression outcome in patients with atopic dermatitis and psoriasis. World J Biol Psychiatry. 2017;18(8):604–14.
Simpson EL, Bieber T, Eckert L, Wu R, Ardeleanu M, Graham NMH, et al. Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74(3):491–8.
Kawana S, Kato Y, Omi T. Efficacy of a 5-HT1a receptor agonist in atopic dermatitis. Clin Exp Dermatol. 2010;35(8):835–40.
Cheng BT, Silverberg JI. Depression and psychological distress in US adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):179–85.
Thyssen JP, Hamann CR, Linneberg A, Dantoft TM, Skov L, Gislason GH, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy. 2018;73(1):214–20.
Rønnstad ATM, et al. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;79(3):448–456.e30.
Patel KR, Immaneni S, Singam V, Rastogi S, Silverberg JI. Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):402–10.
Singh P, Silverberg JI. Underscreening of depression in U.S. outpatients with atopic dermatitis and psoriasis. Br J Dermatol. 2020;182(4):1057–9 Despite there being well-established associations of AD with depression and suicidality, screening of AD patients for depression remains very low in clinical practice.
Patel KR, Singam V, Vakharia PP, Chopra R, Sacotte R, Patel N, et al. Measurement properties of three assessments of burden used in atopic dermatitis in adults. Br J Dermatol. 2019;180(5):1083–9.
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Measurement properties of the hospital anxiety and depression scale used in atopic dermatitis in adults. J Invest Dermatol. 2019;139(6):1388–91.
Silverberg JI, Lee B, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, et al. Measurement properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in adult patients with atopic dermatitis. Dermatitis. 2020; In Press, Publish Ahead of Print.
Koo J, Lebwohl A. Psycho dermatology: the mind and skin connection. Am Fam Physician. 2001;64(11):1873–8.
Ko LN, Garza-Mayers AC, St John J, Strazzula L, Vedak P, Shah R, et al. Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial. JAMA Dermatology. 2018;154(5):529–36.
Kroshinsky D, Cotliar J, Hughey LC, Shinkai K, Fox LP. Association of dermatology consultation with accuracy of cutaneous disorder diagnoses in hospitalized patients: a multicenter analysis. JAMA Dermatology. 2016;152(4):477–80.
Noe MH, Rosenbach M. Inpatient dermatologists—crucial for the management of skin diseases in hospitalized patients. JAMA Dermatology. 2018;154(5):524–5.
Arkwright PD, Motala C, Subramanian H, Spergel J, Schneider LC, Wollenberg A. Management of difficult-to-treat atopic dermatitis. J Allergy Clin Immunol Pract. 2013;1(2):142–51.
Mistry N, et al. A review of the diagnosis and management of erythroderma (generalized red skin). Adv Skin Wound Care. 2015;28(5).
Rothe MJ, Bernstein ML, Grant-Kels JM. Life-threatening erythroderma: diagnosing and treating the “red man”. Clin Dermatol. 2005;23(2):206–17.
Bruno TF, Grewal P. Erythroderma: a dermatologic emergency. CJEM. 2015;11(3):244–6.
Hsu DY, Shinkai K, Silverberg JI. Epidemiology of eczema herpeticum in hospitalized U.S. children: analysis of a nationwide cohort. J Invest Dermatol. 2018;138(2):265–72.
Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126(1):3–12.
Joly P, Benoit-Corven C, Baricault S, Lambert A, Hellot MF, Josset V, et al. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study. J Invest Dermatol. 2007;127(12):2766–71.
Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups—variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340–57 Reviews key nuances in the epidemiology, pathophysiology, clinical presentation and treatment of AD in non-White ethnic groups.
Noda S, Suárez-Fariñas M, Ungar B, Kim SJ, de Guzman Strong C, Xu H, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol. 2015;136(5):1254–64.
Leung DY. Atopic dermatitis: age and race do matter! J Allergy Clin Immunol. 2015;136(5):1265–7.
Vachiramon V, Tey HL, Thompson AE, Yosipovitch G. Atopic dermatitis in African American children: addressing unmet needs of a common disease. Pediatr Dermatol. 2012;29(4):395–402.
Allen HB, Jones NP, Bowen SE. Lichenoid and other clinical presentations of atopic dermatitis in an inner city practice. J Am Acad Dermatol. 2008;58(3):503–4.
Shaw FM, Luk KMH, Chen KH, Wrenn G, Chen SC. Racial disparities in the impact of chronic pruritus: a cross-sectional study on quality of life and resource utilization in United States veterans. J Am Acad Dermatol. 2017;77(1):63–9.
Ezzo D. Treatment and managed care issues of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S124–s131.
Nicol NH, Boguniewicz M, Strand M, Klinnert MD. Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program. J Allergy Clin Immunol Pract. 2014;2(4):400–6.
Nelson AA, Miller AD, Fleischer AB, Balkrishnan R, Feldman SR. How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat. 2006;17(4):224–8.
Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812–24.
Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, et al. Association of itch triggers with atopic dermatitis severity and course in adults. Ann Allergy Asthma Immunol. 2020;125:552–559.e2.
González-López G, Ceballos-Rodríguez RM, González-López JJ, Feito Rodríguez M, Herranz-Pinto P. Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2017;177(3):688–95.
Eichenfield LF, Ahluwalia J, Waldman A, Borok J, Udkoff J, Boguniewicz M. Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017;139(4):S49–57.
Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32.
Devillers AC, et al. Treatment of refractory atopic dermatitis using ‘wet-wrap’ dressings and diluted corticosteroids: results of standardized treatment in both children and adults. Dermatology. 2002;204(1):50–5.
Goodyear HM, Spowart K, Harper JI. Wet-wrap’ dressings for the treatment of atopic eczema in children. Br J Dermatol. 1991;125(6):604.
Wolkerstorfer A, Visser RL, de Waard FB, van der Spek, Mulder PGH, Oranje AP. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution. Br J Dermatol. 2000;143(5):999–1004.
Pei AY, Chan HH, Ho KM. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children. Pediatr Dermatol. 2001;18(4):343–8.
Devillers ACA, Oranje AP. Efficacy and safety of ‘wet-wrap’ dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol. 2006;154(4):579–85.
Cadmus SD, Sebastian KR, Warren D, Hovinga CA, Croce EA, Reveles LA, et al. Efficacy and patient opinion of wet-wrap dressings using 0.1% triamcinolone acetonide ointment vs cream in the treatment of pediatric atopic dermatitis: a randomized split-body control study. Pediatr Dermatol. 2019;36(4):437–41.
Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol. 2014;133(2):429–38.
Schmitt J, Schäkel K, Fölster-Holst R, Bauer A, Oertel R, Augustin M, et al. Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol. 2010;162(3):661–8.
Yu SH, et al. A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol. 2018;78(4):733–740.e11.
Drucker AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, Spuls PI, Irvine AD, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol. 2018;178(3):768–75.
Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30(5):729–47.
Waljee AK, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415.
Yasir M, et al. Corticosteroid adverse effects, in StatPearls. Treasure Island (FL); 2020.
Davis DM, Borok J, Udkoff J, Lio P, Spergel J. Atopic dermatitis: phototherapy and systemic therapy. Semin Cutan Med Surg. 2017;36(3):118–23.
Dennis M, Bhutani T, Koo J, Liao W. Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. J Dermatol Treat. 2013;24(1):2–6.
Farahnik B, Beroukhim K, Danesh M, Nakamura M, Abrouk M, Zhu TH, et al. Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: a prospective pilot study. J Am Acad Dermatol. 2016;75(5):1068–71.
Jeon C, Yan D, Nakamura M, Sekhon S, Bhutani T, Berger T, et al. Frequency and management of sleep disturbance in adults with atopic dermatitis: a systematic review. Dermatol Ther. 2017;7(3):349–64.
Ramirez FD, Chen S, Langan SM, Prather AA, McCulloch CE, Kidd SA, et al. Association of atopic dermatitis with sleep quality in children. JAMA Pediatr. 2019;173(5):e190025–5.
Chang YS, Chiang BL. Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol. 2018;142(4):1033–40.
Singh P, Silverberg J. Real-world outpatient prescription patterns for atopic dermatitis in the United States. Dermatitis. 2019;30(5):294–9.
Chang YS, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, et al. Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial. JAMA Pediatr. 2016;170(1):35–42.
Chang Y-S, Chiang B-L. Mechanism of sleep disturbance in children with atopic dermatitis and the role of the circadian rhythm and melatonin. Int J Mol Sci. 2016;17(4):462–2.
DuBose JR, Hadi K. Improving inpatient environments to support patient sleep. Int J Qual Health Care. 2016;28(5):540–53.
Ntuen E, Taylor SL, Kinney M, O'Neill JL, Krowchuk DP, Feldman SR. Physicians’ perceptions of an eczema action plan for atopic dermatitis. J Dermatolog Treat. 2010;21(1):28–33.
Rork JF, Sheehan WJ, Gaffin JM, Timmons KG, Sidbury R, Schneider LC, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–2.
Miceli A, Krishnamurthy K. Use of a dermatology-specific discharge form to improve outpatient follow-up after inpatient dermatology consultation. J Am Acad Dermatol. 2020;83(4):1164–6.
Silverberg JI. Health care utilization, patient costs, and access to care in us adults with eczema: a population-based study. JAMA Dermatology. 2015;151(7):743–52.
Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol. 2002;147(5):920–5.
Sauaia A, Dellavalle RP. Health care inequities: an introduction for dermatology providers. Dermatol Clin. 2009;27(2):103–v.
Cheng BT, Silverberg JI. Predictors of hospital readmission in US children and adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(1):64–69.e2.
Conflicts of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Hospital-Based Dermatology
About this article
Cite this article
Narla, S., Silverberg, J.I. Management of atopic dermatitis in the inpatient setting. Curr Derm Rep (2021). https://doi.org/10.1007/s13671-021-00332-7
- Atopic dermatitis
- Mental health